
Reading Passage Question
A study of the benefits of a family of cholesterol-lowering drugs used in the treatment of heart attacks has shown that while the greatest benefits are enjoyed by those at greatest risk of a vascular event, every person at risk can gain considerable benefits from the treatment.These findings have led to calls that it should be offered to anybody at risk of a heart attack or stroke. It has long been known that the treatment, if administered daily to the group most at risk of an attack, cuts that risk by a third. At present, doctors prescribe the treatment only once they have considered a number of factors, including cholesterol level, blood pressure, body fat levels and whether the patient smokes. The new evidence suggests that patients with less than very high levels of cholesterol will also experience a significant drop in their cholesterol levels and a consequent lower risk of a vascular event. In fact, it concludes that the benefits of the treatment are directly proportional to the size of the reduction in cholesterol levels that might be achieved and not the level at which the intervention begins.
“A study of the benefits of a family of cholesterol-lowering drugs”- is a passage for the GMAT that addresses reading comprehension. Candidates must have a firm understanding of GMAT reading comprehension in English. This GMAT reading comprehension section consists of five comprehension questions. The purpose of the GMAT Reading Comprehension questions is to assess a candidate's capacity to understand, evaluate, and apply knowledge or ideas. By responding to the GMAT Reading Comprehension Practice Questions section, candidates can actively practice.
Solutions and Explanation
Answer: (E)
Explanation: The passage claims that it was later discovered that patients of all different patient types benefited from the treatment. This led to the demand that the treatment be made available to anyone who was at risk of having a heart attack or stroke. According to this interpretation, the final option is the right answer.
Answer: (E)
Explanation: The passage mentions a class of cholesterol-lowering medications, but it also says that the treatment itself is given every day. According to this, the final option is the correct answer. The remaining options are all wrong answers as the statements they have are distorted.
Answer: (D)
Explanation: The fourth option is the correct answer. This is the case because the sentence there best sums up the conclusion. Given the current state of the evidence, it specifies who will profit from the treatment. The remaining options are all wrong answers as they are not the correct summarizations of the conclusion that can be evaluated from the evidence of the study.
Answer: (E)
Explanation: It goes without saying that the extent of the reduction in cholesterol levels directly relates to the treatment's advantages. In light of this, it is accurate to state that physicians should give patients with the lowest possible cholesterol levels less of a priority than they should. With this interpretation, the final option is the right answer.
Answer: (C)
Explanation: The best answer is the third option. This is because, if true, it would significantly undermine the specific claim that was the subject of the question. This means that patients with cholesterol levels that are not high will also experience a significant drop in their cholesterol levels. As a result, they would have a much lower risk of experiencing a vascular event.
Suggested GMAT Reading Comprehension Samples
*The article might have information for the previous academic years, please refer the official website of the exam.